Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Based on the evidence that hemochromatosis, an iron-overload disease, drives
hepatocellular carcinoma
, we hypothesized that chronic exposure to excess iron, either due to genetic or environmental causes, predisposes an individual to cancer. Using pancreatic cancer as our primary focus, we employed cell culture studies to interrogate the connection between excess iron and cancer, and combined
in vitro
and
in vivo
studies to explore the connection further.
Ferric ammonium citrate
was used as an exogenous iron source. Chronic exposure to excess iron induced epithelial-mesenchymal transition (EMT) in normal and cancer cell lines, loss of p53, and suppression of p53 transcriptional activity evidenced from decreased expression of p53 target genes (p21, cyclin D1, Bax, SLC7A11). To further extrapolate our cell culture data, we generated
EL
-
Kras
G12D
(
EL-Kras
) mouse (pancreatic neoplastic mouse model) expressing
Hfe
+/+
and
Hfe
-/-
genetic background. p53 target gene expression decreased in
EL-Kras
/
Hfe
-/-
mouse pancreas compared to
EL-Kras
/
Hfe
+/+
mouse pancreas. Interestingly, the incidence of acinar-to-ductal metaplasia and cystic pancreatic neoplasms (CPN) decreased in
EL-Kras
/
Hfe
-/-
mice, but the CPNs that did develop were larger in these mice than in
EL-Kras
/
Hfe
+/+
mice. In conclusion, these
in vitro
and
in vivo
studies support a potential role for chronic exposure to excess iron as a promoter of more aggressive disease via p53 loss and SLC7A11 upregulation within pancreatic epithelial cells.
...
PMID:Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer. 3237 2
